KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Non-Current Debt (2016 - 2018)

CareDx's Non-Current Debt history spans 6 years, with the latest figure at $13.4 million for Q3 2018.

  • On a quarterly basis, Non-Current Debt fell 36.79% to $13.4 million in Q3 2018 year-over-year; TTM through Sep 2018 was $13.4 million, a 36.79% decrease, with the full-year FY2017 number at $18.3 million, up 1570.13% from a year prior.
  • Non-Current Debt hit $13.4 million in Q3 2018 for CareDx, roughly flat from $13.3 million in the prior quarter.
  • Over the last five years, Non-Current Debt for CDNA hit a ceiling of $21.2 million in Q3 2017 and a floor of $1.1 million in Q4 2016.
  • Historically, Non-Current Debt has averaged $10.8 million across 5 years, with a median of $11.7 million in 2015.
  • Biggest five-year swings in Non-Current Debt: plummeted 91.48% in 2016 and later surged 1570.13% in 2017.
  • Tracing CDNA's Non-Current Debt over 5 years: stood at $5.5 million in 2014, then soared by 136.42% to $12.9 million in 2015, then plummeted by 91.48% to $1.1 million in 2016, then surged by 1570.13% to $18.3 million in 2017, then dropped by 27.01% to $13.4 million in 2018.
  • Business Quant data shows Non-Current Debt for CDNA at $13.4 million in Q3 2018, $13.3 million in Q2 2018, and $1.7 million in Q1 2018.